Could Pfizer really buy Bristol-Myers Squibb? Despite the latter's $112 billion market cap, Citi analyst Andrew Baum lays out the case for why it makes sense.
Could Bristol-Myers Squibb stock really jump another 14% after rallying 12% so far in 2018? According to Morgan Stanley, the answer is 'yes.'
All three major indices gained more than 1% Thursday.
You can buy it here or you can buy it higher.
Stocks finished higher on Wednesday.